<DOC>
	<DOCNO>NCT00025103</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining chemotherapy peripheral stem cell transplant may allow doctor give high dos chemotherapy drug kill tumor cell . PURPOSE : This phase II trial study well chemotherapy follow surgery radiation therapy without stem cell transplant work treat patient relapsed refractory Wilms ' tumor clear cell sarcoma kidney .</brief_summary>
	<brief_title>Chemotherapy Followed Surgery Radiation Therapy With Without Stem Cell Transplant Treating Patients With Relapsed Refractory Wilms ' Tumor Clear Cell Sarcoma Kidney</brief_title>
	<detailed_description>OBJECTIVES : - Determine survival rate patient relapse refractory Wilms ' tumor clear cell sarcoma kidney treat chemotherapy follow surgical resection adjuvant radiotherapy without autologous stem cell rescue . - Determine efficacy toxicity regimens patient . - Determine prognostic variable patient treat regimen . OUTLINE : Patients assign one three treatment regimen . - Regimen A ( patient initial stage I tumors previously treat vincristine without dactinomycin relapse least 6 month diagnosis ) : Patients receive vincristine IV weekly week 1-10 every 3 week week 11-52 , dactinomycin IV every 3 week week 1-52 , doxorubicin IV 6 hour every 3 week week 1-34 ( week 1-28 pulmonary radiotherapy plan ) . Patients undergo surgical resection radiotherapy 6 week therapy . - Regimen B ( patient initial stage II tumors previously treat vincristine dactinomycin relapse least 6 month diagnosis ) : Patients receive cyclophosphamide IV twice daily day 1-2 22-23 , etoposide IV 1 hour day 1-3 , doxorubicin IV 6 hour day 22 23 . Treatment repeat every 42 day total 4 course . Patients undergo surgical resection radiotherapy 2 course chemotherapy . Patients achieve complete response 4 course chemotherapy undergo autologous bone marrow transplantation regimen C. - Regimen C ( patient first relapse OR progression first-line therapy OR second subsequent relapse previously treat regimens A B ) : Patients receive carboplatin IV 1 hour day 1 , etoposide IV 2 hour day 1-3 22-24 , cyclophosphamide IV twice daily day 22 23 . Treatment repeat every 42 day total 3 course . Patients may undergo surgical resection prior stem cell rescue . Beginning within 6 week completion chemotherapy , patient receive melphalan IV day -1 . Autologous peripheral blood stem cell bone marrow reinfused day 0 . Patients undergo radiotherapy transplantation . Patients follow every 8 week 1 year , every 12 week 1 year , every 6 month thereafter . PROJECTED ACCRUAL : Approximately 75 patient ( 25 regimens A B 50 regimen C ) accrue study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<mesh_term>Sarcoma , Clear Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Dactinomycin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis Wilms ' tumor clear cell sarcoma kidney , meet 1 follow criterion : First relapse Refractory ( progression firstline therapy ) Patients second subsequent relapse allow previously treat vincristine , dactinomycin , doxorubicin combination chemotherapy ( VCR/DACT/DOX ) Metachronous tumor contralateral kidney allow previously treat VCR/DACT/DOX No rhabdoid tumor kidney Previously treat UK Wilms ' tumor study PATIENT CHARACTERISTICS : Age : Under 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>recurrent Wilms tumor childhood kidney tumor</keyword>
	<keyword>clear cell sarcoma kidney</keyword>
</DOC>